Navigation Links
Thermage, Inc. Announces Initial Shipments of Cellulite Product
Date:3/12/2008

HAYWARD, Calif., March 12 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM), a leader in non-invasive tissue tightening in the aesthetic industry, today announced it has begun initial shipments of its ThermaTip(TM) CL treatment tips for use in the Company's cellulite procedure. The procedure noticeably reduces the appearance of cellulite after just a single treatment. The treatment tip and procedure are the result of 21 months of clinical and technological development and use the FDA cleared ThermaCool(R) system for the temporary improvement in the appearance of cellulite.

"We began shipments of our ThermaTip CL treatment tip on track and within the timeframe we expected," said Stephen J. Fanning, Chairman of the Board, President and Chief Executive Officer at Thermage. "Cellulite offers a new market opportunity for our Company and we expect the new tip to provide a solid contribution to our revenue in 2008."

The ThermaTip CL and cellulite procedure by Thermage incorporate the Company's patented monopolar capacitive radiofrequency technology. The advanced deep heating ThermaTip CL rebuilds collagen connective tissues and improves blood flow to the tissue helping to smooth the appearance of the skin's surface.

About Thermage

Thermage's innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti- aging" market. For more information about Thermage, call 1-510-259-7117 or log on to http://www.thermage.com.

This press release may contain forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 including the statement regarding revenue contribution of the cellulite treatment tip. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Thermage's actual results to differ materially from the statements contained herein including the risk that the new tip does not achieve commercial acceptance or that such acceptance is delayed, among other risks. Further information on potential risk factors that could affect Thermage's business are detailed in the Company's Form 10-Q for the period ended September 30, 2007. Undue reliance should not be placed on forward-looking statements, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Results vary from subtle to dramatic. Generally improvements may be immediately visible and continue to improve for up to six months. Results are long lasting and depend on your skin condition and the aging process.


'/>"/>
SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
2. Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer
3. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
4. Thermage, Inc. to Present at the Maxim Group Growth Conference
5. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
6. NHP Announces Management Promotions
7. WellPoint Announces Appearances at Upcoming Conferences
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference
9. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
10. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
11. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... which is has been collaborating with doctors and hospitals to make transformative changes ... the world’s leading cell therapy minds this week in discussing breakthroughs in cellular ...
(Date:4/28/2016)... ... ... reminds us that May is National Stroke Awareness Month. According to the Centers for ... the United States; someone has one every 40 seconds. Annually, almost 800,000 strokes occur ... A stroke is when blood flow to the brain is blocked or when a ...
(Date:4/28/2016)... Philadelphia, PA (PRWEB) , ... April 28, 2016 ... ... Barbara Browne, M.D. has been named a Top Doc in Physical Medicine and ... in conjunction with Castle Connolly Medical, Ltd. by randomly surveying physicians and medical ...
(Date:4/28/2016)... MO (PRWEB) , ... April 28, 2016 , ... Denise McCormick Baich had written poetry ... 2009 the poetry arrived again much like a tsunami and took on a more spiritual ... to her encouraged her to do more with it than just file it away. Friends ...
(Date:4/28/2016)... ... April 28, 2016 , ... Prescription ... co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy program. ... medications from over 180 American pharmaceutical companies for $35 per month, per ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
(Date:4/27/2016)... April 27, 2016  Hologic, Inc. (Nasdaq: ... results for the fiscal second quarter ended March ... of $0.24 increased 41.2%, and non-GAAP diluted EPS ... increased 5.8% on a reported basis, and 6.3% ... "We posted another good quarter, highlighted by 14.6% ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: